Bluelinea Société Anonyme Past Earnings Performance
Past criteria checks 0/6
Bluelinea Société Anonyme has been growing earnings at an average annual rate of 11.9%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 10.4% per year.
Key information
11.9%
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment Industry Growth | 21.6% |
| Revenue growth rate | 10.4% |
| Return on equity | -115.3% |
| Net Margin | -17.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Bluelinea Société Anonyme makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 10 | -2 | 0 | 0 |
| 31 Mar 24 | 10 | -2 | 0 | 0 |
| 31 Dec 23 | 10 | -2 | 0 | 0 |
| 30 Jun 23 | 11 | -2 | 6 | 0 |
| 31 Mar 23 | 11 | -2 | 6 | 0 |
| 31 Dec 22 | 11 | -2 | 6 | 0 |
| 30 Sep 22 | 11 | -2 | 6 | 0 |
| 30 Jun 22 | 10 | -2 | 6 | 0 |
| 31 Mar 22 | 9 | -3 | 5 | 0 |
| 31 Dec 21 | 8 | -3 | 5 | 0 |
| 30 Sep 21 | 8 | -3 | 4 | 0 |
| 30 Jun 21 | 8 | -3 | 5 | 0 |
| 31 Mar 21 | 7 | -3 | 5 | 0 |
| 31 Dec 20 | 7 | -3 | 5 | 0 |
| 30 Sep 20 | 7 | -3 | 6 | 0 |
| 30 Jun 20 | 7 | -3 | 5 | 0 |
| 31 Mar 20 | 7 | -3 | 4 | 0 |
| 31 Dec 19 | 7 | -3 | 4 | 0 |
| 30 Sep 19 | 7 | -3 | 4 | 0 |
| 30 Jun 19 | 7 | -3 | 5 | 0 |
| 31 Mar 19 | 7 | -3 | 5 | 0 |
| 31 Dec 18 | 7 | -3 | 5 | 0 |
| 30 Sep 18 | 7 | -3 | 4 | 0 |
| 30 Jun 18 | 7 | -2 | 5 | 0 |
| 31 Mar 18 | 7 | -3 | 5 | 0 |
| 31 Dec 17 | 7 | -3 | 5 | 0 |
| 30 Sep 17 | 7 | -3 | 5 | 0 |
| 30 Jun 17 | 6 | -5 | 5 | 0 |
| 31 Mar 17 | 6 | -5 | 5 | 0 |
| 31 Dec 16 | 7 | -3 | 5 | 0 |
| 30 Sep 16 | 7 | -2 | 5 | 0 |
| 30 Jun 16 | 7 | -2 | 5 | 0 |
| 31 Mar 16 | 7 | -1 | 5 | 0 |
| 31 Dec 15 | 7 | -1 | 5 | 0 |
| 30 Sep 15 | 7 | -1 | 4 | 1 |
| 30 Jun 15 | 6 | -2 | 4 | 0 |
| 31 Mar 15 | 5 | -2 | 4 | 0 |
| 31 Dec 14 | 5 | -2 | 4 | 0 |
| 31 Dec 13 | 3 | -1 | 2 | 0 |
Quality Earnings: ALBLU is currently unprofitable.
Growing Profit Margin: ALBLU is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ALBLU is unprofitable, but has reduced losses over the past 5 years at a rate of 11.9% per year.
Accelerating Growth: Unable to compare ALBLU's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ALBLU is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).
Return on Equity
High ROE: ALBLU has a negative Return on Equity (-115.34%), as it is currently unprofitable.